Clinical trials · Chicago, IL
Recurrent Glioblastoma, IDH-Wildtype clinical trials in Chicago
We’re tracking 4 recruiting recurrent glioblastoma, idh-wildtype studies with a site in or near Chicago — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Chicago
- NCT05765812RecruitingPhase 1/Phase 2
Debio 0123 with temozolomide for recurrent or new glioblastoma
This early-phase study tests Debio 0123 (an anticancer medicine) combined with temozolomide, and for newly diagnosed patients also with radiation. It aims to see whether this treatment combination can slow or control glioblastoma in adults.
Chicago, IllinoisAges 18 years+ - NCT06860594RecruitingPhase 1
Triapine plus radiation for recurrent brain tumors
This trial tests whether adding an experimental drug called triapine to a second round of radiation therapy can help treat brain tumors that have come back after initial treatment. It may be a good option for people with recurrent glioblastoma or astrocytoma who meet safety criteria.
Chicago, IllinoisAges 18 years+ - NCT05432804RecruitingPhase 1/Phase 2
Selinexor added to temozolomide for recurring brain glioblastoma
This trial studies whether adding selinexor to the standard chemotherapy temozolomide (with radiation) can better treat glioblastoma that has come back after prior treatment. If you meet specific tumor, health, and lab requirements, the goal is to slow tumor growth or improve symptoms.
Chicago, IllinoisAges 18 years+ - NCT06410248RecruitingPhase 1
Triapine and temozolomide for recurrent glioblastoma
This trial tests a combination of two drugs, triapine and temozolomide, for people whose glioblastoma has come back after initial treatment. The goal is to see if this combination can help control the tumor.
Chicago, IllinoisAges 18 years+
Hear when a new Recurrent Glioblastoma, IDH-Wildtype trial opens near Chicago, IL
We’ll email you when one opens near Chicago, IL — at most once a week, no account needed, unsubscribe anytime.
Recurrent Glioblastoma, IDH-Wildtype trials in other cities
Where these studies are running near Chicago
Institutions with a site for the recruiting recurrent glioblastoma, idh-wildtype studies listed above.
- Northwestern University · 2 studies
- University of Chicago · 2 studies
- Northwestern Memorial Hospital
- University of Chicago Medicine-Orland Park
What taking part in a recurrent glioblastoma, idh-wildtype study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent glioblastoma, idh-wildtype studies in Illinois.
Common questions
- Are there recurrent glioblastoma, idh-wildtype clinical trials near Chicago?
- Yes. We're currently tracking 4 recruiting recurrent glioblastoma, idh-wildtype studies with a site near Chicago, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent glioblastoma, idh-wildtype study near Chicago?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Chicago to take part?
- Not necessarily. These studies have a site near Chicago, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent glioblastoma, idh-wildtype trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent glioblastoma, idh-wildtype studies open near Chicago regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.